Stay updated on Immunotherapy Combinations in Metastatic Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy Combinations in Metastatic Lung Cancer Clinical Trial page.

Latest updates to the Immunotherapy Combinations in Metastatic Lung Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedThe record history now lists the latest revision as v3.6.3, replacing the prior v3.6.2 entry. This indicates an update to the revision log rather than substantive changes to the study content.SummaryDifference0.0%

- Check24 days agoChange DetectedThe history now shows a new revision label v3.6.2 replacing the previous v3.6.0, indicating a routine site maintenance update to the page version.SummaryDifference0.0%

- Check38 days agoChange DetectedThe record shows that recruitment for the trial has ended, and the history adds a new revision label v3.6.0 while removing the previous revision v3.5.5.SummaryDifference0.2%

- Check45 days agoChange DetectedA new revision label, v3.5.5, was added to the page history. This updates the version reference from the previous v3.5.4.SummaryDifference0.0%

- Check67 days agoChange DetectedStudy Morpheus Lung (NCT03337698) was closed early as the sponsor decided not to continue development of certain treatment combinations. The history now reflects termination and updates to results-related sections (Results Posted, Adverse Events, Outcome Measures, Baseline Characteristics, and Study Status).SummaryDifference0.5%

- Check81 days agoChange DetectedThe page now displays a revised site version (v3.5.3) instead of v3.5.2, indicating a small update to the website's build. This change does not modify the study data or other visible content.SummaryDifference0.0%

Stay in the know with updates to Immunotherapy Combinations in Metastatic Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy Combinations in Metastatic Lung Cancer Clinical Trial page.